Characterisation of the Time-course Response of UV-induced Erythema
NCT04290273 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2024-03-15
Summary
Erythema is a physiological response to an insult on the skin. One such insult is ultraviolet (UV) radiation, with the resultant erythema also known as sunburn. It is a reddening of the skin as a result of increased blood flow to the area. By controlled exposure to UV radiation, a minimal erythema dose (MED) indicative of threshold erythemal sensitivity to the exposure waveband may be determined - this is determined visually by a trained clinician as the dose of light required to cause a just perceptible reddening of the skin. The MED of a specific patient on a specific skin site is an important measurement - it can allow for determination of initial dose in UV phototherapy, provides an indication of background levels of photosensitivity in diagnostic phototesting and may be influenced by exogenous factors, such as photoactive drugs.
The erythema response has been measured previously using non-invasive hand-held devices for a variety of UV exposures, including narrow-band (NB-)UVB, UVA and UVA1. Typically, the participant will be exposed in the morning (t = 0h) and have a reading taken immediately after. These readings are assessed visually by a trained clinician, or occasionally reflectance devices are used quantify erythema. The participant will then return at the end of the working day (t \~ 8h) for another reading, and again the next morning for another reading (t \~ 24h). This results in large gaps in the knowledge of erythemal response over time.
In this study the investigators aim to characterise the erythema response as a result of UV insult using a wearable erythema device to take continual measurements. This would allow us to more accurately determine the time point of peak erythema, which would inform and potentially change our current practice in reading MEDs. The investigators have previous experience of studies using reflectance devices to measure erythema time course at fixed intervals, however there are still gaps in the knowledge of the time course response of erythema.
There is no expected health benefit to participants in this study, however they may gain a better understanding of their responses to ultraviolet light MED testing. Controlled UV exposures are commonplace in our practice in the Photobiology Unit and it is not foreseen that there are any risks to participation in the study.
The primary objective in this study is to determine when the peak erythema index occurs in a healthy volunteer group. Success of this outcome will help fill in these gaps in the knowledge about the time course of erythema. The secondary objective is to determine if there is any difference in MED and/or peak erythema if the UV exposure is delivered in the morning vs. the afternoon. The outcomes of the research will be 20 sets (2 per participant) of continuous 48-hour erythema measurements.
Conditions
- Erythema
Interventions
- DIAGNOSTIC_TEST
-
MED Test
Participant is irradiated with several doses of UV light on small areas of the outer thigh. 24 hours later this area is visually inspected for erythema, and the minimal erythemal dose (MED) is determined.
- DEVICE
-
Wearing device
Participants wear a portable erythema measurement device for 48 hours. The device shines light on the skin at frequent intervals and measures skin 'redness'. The device is removed by a technician after the 48 hours.
Sponsors & Collaborators
-
NHS Tayside
collaborator OTHER_GOV -
University of Dundee
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-09-30
- Primary Completion
- 2024-11-30
- Completion
- 2024-11-30
More Related Trials
-
Potential Benefits of Laser Treatment on Skin Blood Flow and Sweating in Burn Survivors
NCT04947449 ·Status: TERMINATED
-
Determine the Haemostatic Efficacy of TT-173, Reducing the Bleeding Time in the Donor Site of Skin Grafting
NCT02012569 ·Status: COMPLETED ·Phase: PHASE2
-
Compare the Efficacy of Mepilex and Keramatrix in Second Degree Burn Wounds
NCT01790763 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Cutaneous Microcirculation After Plasma Therapy
NCT02417818 ·Status: COMPLETED ·Phase: NA
-
The Use of Fractional Ablative CO2 Laser vs Control on Acute Traumatic Injuries to Prevent Scar Formation
NCT03888703 ·Status: COMPLETED ·Phase: NA
-
Deep Tissue Injury Treatment With MIST Therapy Versus Standard Care: REVERSE DTI Study
NCT01540981 ·Status: TERMINATED ·Phase: NA
-
Therapeutic Effect of the Wireless Micro Current Stimulation in Pediatric Deep Dermal Burns and Scald Injuries
NCT02712580 ·Status: UNKNOWN ·Phase: NA
-
Skin Imaging With Technologies in Development
NCT00764920 ·Status: ACTIVE_NOT_RECRUITING
-
Pilot Study of the Effect of Laser on Reversing Chronic Radiation Injury
NCT01910818 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Dilute Bleach Compresses for Radiation Dermatitis
NCT04851522 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Dermal Cryotherapy for Treatment of Pigmented Lesions
NCT02848742 ·Status: COMPLETED ·Phase: NA
-
Factor XIII in Major Burns Coagulation
NCT03188913 ·Status: UNKNOWN
-
The Effect of Platelet Rich Plasma on Pain at Skin Graft Donor Sites
NCT03937765 ·Status: TERMINATED ·Phase: NA
-
A Prospective, Open Label, Multicenter Trial for Evaluating the Efficacy of Treating and Managing Wounds in Elderly Population in Specialized Nursing Facilities Using RD1
NCT04577183 ·Status: TERMINATED ·Phase: NA
-
Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention
NCT03795116 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Pulsed-Dyed Laser on Scar Formation
NCT00852280 ·Status: COMPLETED ·Phase: NA
-
TMFI Enhances Skin Surface and Epidermal PpIX Fluorescence
NCT04221126 ·Status: COMPLETED ·Phase: PHASE4
-
Donor Site Healing Response to Low Level Laser Therapy Following Skin Graft Surgery
NCT05907915 ·Status: COMPLETED ·Phase: NA
-
Use of Pressure Garments for Burn Scars
NCT00675974 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Fractional Laser Therapy and Dermabrasion for Scar Revision
NCT01409863 ·Status: WITHDRAWN ·Phase: NA
-
Using Skin Blood Flow to Measure the Effect of Different Doses of Negative Pressure Therapy
NCT06690749 ·Status: COMPLETED ·Phase: NA
-
Study of the Effects of the Pulsed-dye Laser at 585nm and 595nm to Treat Post-operative Scars on Suture-removal Day
NCT00482144 ·Status: COMPLETED ·Phase: NA
-
Medihoney and Santyl for Burn Injuries
NCT02250183 ·Status: TERMINATED ·Phase: NA
-
Evaluating the Efficacy of the Melanocyte Keratinocyte Transplantation Procedure in the Treatment of Vitiligo
NCT04374435 ·Status: TERMINATED ·Phase: NA
-
Significance of Platelet Indices and Ratios in Different Degrees of Burn
NCT06612385 ·Status: NOT_YET_RECRUITING